These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 16609008

  • 21. Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells.
    Jewett A, Cavalcanti M, Bonavida B.
    J Immunol; 1997 Nov 15; 159(10):4815-22. PubMed ID: 9366406
    [Abstract] [Full Text] [Related]

  • 22. Quantitative analysis of the effect of CD16 ligation on human NK cell proliferation.
    Warren HS, Kinnear BF.
    J Immunol; 1999 Jan 15; 162(2):735-42. PubMed ID: 9916693
    [Abstract] [Full Text] [Related]

  • 23. [NK cell receptors and related ligands].
    Pan B, Chen YH, Zhu LP, He W, Zhang W.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec 15; 24(6):650-2. PubMed ID: 12905699
    [Abstract] [Full Text] [Related]

  • 24. IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors.
    Sivori S, Cantoni C, Parolini S, Marcenaro E, Conte R, Moretta L, Moretta A.
    Eur J Immunol; 2003 Dec 15; 33(12):3439-47. PubMed ID: 14635054
    [Abstract] [Full Text] [Related]

  • 25. Potent induction of TNF-alpha during interaction of immune effectors with oral tumors as a potential mechanism for the loss of NK cell viability and function.
    Romero-Reyes M, Head C, Cacalano NA, Jewett A.
    Apoptosis; 2007 Nov 15; 12(11):2063-75. PubMed ID: 17713857
    [Abstract] [Full Text] [Related]

  • 26. Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab')2 fragment of anti-CD16 antibody.
    Jewett A, Teruel A, Romero M, Head C, Cacalano N.
    Cancer Immunol Immunother; 2008 Jul 15; 57(7):1053-66. PubMed ID: 18188563
    [Abstract] [Full Text] [Related]

  • 27. CD16 polymorphisms and NK activation induced by monoclonal antibody-coated target cells.
    Bowles JA, Weiner GJ.
    J Immunol Methods; 2005 Sep 15; 304(1-2):88-99. PubMed ID: 16109421
    [Abstract] [Full Text] [Related]

  • 28. Interaction of human immunoglobulin G with CD16 on natural killer cells: ligand clearance, FcgammaRIIIA turnover and effects of metalloproteinases on FcgammaRIIIA-mediated binding, signal transduction and killing.
    Mota G, Moldovan I, Calugaru A, Hirt M, Kozma E, Galatiuc C, Brasoveanu L, Boltz-Nitulescu G.
    Scand J Immunol; 2004 Mar 15; 59(3):278-84. PubMed ID: 15030579
    [Abstract] [Full Text] [Related]

  • 29. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen.
    Pérez-Villar JJ, Melero I, Rodríguez A, Carretero M, Aramburu J, Sivori S, Orengo AM, Moretta A, López-Botet M.
    J Immunol; 1995 Jun 01; 154(11):5779-88. PubMed ID: 7751628
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of anti-GD3-ganglioside antibody-induced proliferation of human CD8+ T cells by CD16+ natural killer cells.
    Claus C, Schlaak J, Dittmayer M, Meyer zum Büschenfelde K, Dippold W.
    Eur J Immunol; 1994 May 01; 24(5):1208-12. PubMed ID: 8181530
    [Abstract] [Full Text] [Related]

  • 31. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor.
    Borrego F, Masilamani M, Kabat J, Sanni TB, Coligan JE.
    Mol Immunol; 2005 Feb 01; 42(4):485-8. PubMed ID: 15607803
    [Abstract] [Full Text] [Related]

  • 32. CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells.
    Palmieri G, Tullio V, Zingoni A, Piccoli M, Frati L, Lopez-Botet M, Santoni A.
    J Immunol; 1999 Jun 15; 162(12):7181-8. PubMed ID: 10358164
    [Abstract] [Full Text] [Related]

  • 33. Isolation and characterization of anti-FcgammaRIII (CD16) llama single-domain antibodies that activate natural killer cells.
    Behar G, Sibéril S, Groulet A, Chames P, Pugnière M, Boix C, Sautès-Fridman C, Teillaud JL, Baty D.
    Protein Eng Des Sel; 2008 Jan 15; 21(1):1-10. PubMed ID: 18073223
    [Abstract] [Full Text] [Related]

  • 34. Decreased natural killer (NK) cell function in chronic NK cell lymphocytosis associated with decreased surface expression of CD11b.
    Orange JS, Chehimi J, Ghavimi D, Campbell D, Sullivan KE.
    Clin Immunol; 2001 Apr 15; 99(1):53-64. PubMed ID: 11286541
    [Abstract] [Full Text] [Related]

  • 35. Compensatory effect of TNFalpha on low natural killer activity in the elderly.
    Myśliwska J, Bryl E, Trzonkowski P, Myśliwski A.
    Acta Biochim Pol; 2000 Apr 15; 47(2):301-11. PubMed ID: 11051195
    [Abstract] [Full Text] [Related]

  • 36. Beneficial effect of short-term exposure of human NK cells to IL15/IL12 and IL15/IL18 on cell apoptosis and function.
    Sotiriadou NN, Perez SA, Gritzapis AD, Mahaira LG, Salagianni M, Baxevanis CN, Papamichail M.
    Cell Immunol; 2005 Mar 15; 234(1):67-75. PubMed ID: 16024007
    [Abstract] [Full Text] [Related]

  • 37. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
    Liao YH, Jee SH, Sheu BC, Huang YL, Tseng MP, Hsu SM, Tsai TF.
    Br J Dermatol; 2006 Aug 15; 155(2):318-24. PubMed ID: 16882169
    [Abstract] [Full Text] [Related]

  • 38. [Different responses of CD94/NKG2A-bright and CD94/NKG2A-dim NK cell subsets isolated from patients with multiple sclerosis to interferon-beta].
    Li L, Deng YC, Zhao G.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun 15; 23(6):533-5. PubMed ID: 17553351
    [Abstract] [Full Text] [Related]

  • 39. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
    Takahashi E, Kuranaga N, Satoh K, Habu Y, Shinomiya N, Asano T, Seki S, Hayakawa M.
    Scand J Immunol; 2007 Feb 15; 65(2):126-38. PubMed ID: 17257217
    [Abstract] [Full Text] [Related]

  • 40. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway.
    Zeddou M, Greimers R, de Valensart N, Nayjib B, Tasken K, Boniver J, Moutschen M, Rahmouni S.
    Biochem Pharmacol; 2005 Sep 01; 70(5):714-24. PubMed ID: 15978547
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.